Ignite Creation Date:
2025-12-24 @ 5:20 PM
Ignite Modification Date:
2026-02-20 @ 6:03 PM
Study NCT ID:
NCT00976950
Status:
COMPLETED
Last Update Posted:
2014-03-20
First Post:
2009-09-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Post Marketing Surveillance Study Assessing the Long-term Efficacy and Safety of Aptivus Co-administered With Low-dose Ritonavir in Treatment Experienced Patients With HIV-1 Infection in the Daily Clinical Practice.
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-09
Start Date Type:
None
Primary Completion Date:
2011-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-07
Completion Date Type:
ACTUAL
First Submit Date:
2009-09-14
First Submit QC Date:
None
Study First Post Date:
2009-09-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-05-30
Results First Submit QC Date:
None
Results First Post Date:
2012-08-16
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-02-24
Last Update Post Date:
2014-03-20
Last Update Post Date Type:
ESTIMATED